Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare AccuSpan HCV RNA Linearity Panel

SeraCare has expanded its AccuPlex line with the launch of the AccuSpan HCV RNA Linearity Panel. The eight-member panel has been qualified against World Health Organization standards and is made from serial dilutions of high-titer recombinant hepatitis C virus, genotype 1b, with established reactivity for HCV RNA, and one negative control. The panel can be used by researchers, diagnostics manufacturers, and clinical labs to develop, evaluate, and validate HCV molecular test methods. The panel is useful for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, assessing lot-to-lot variability of kits, performing linearity studies, or any time there may be deterioration in diagnostic assays, according to the firm. It uses SeraCare's proprietary AccuPlex technology, which packages recombinant viral material in a way that is stable, replication-deficient, non-infectious, and mimics a real patient sample throughout the diagnostic workflow.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more